Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction.
about
The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616]New insights into insulin: The anti-inflammatory effect and its clinical relevanceIntensive insulin therapy for critically ill patients.Anti-inflammatory effect of rosiglitazone is not reflected in expression of NFkappaB-related genes in peripheral blood mononuclear cells of patients with type 2 diabetes mellitus.Ultra-acute increase in blood glucose during prehospital phase is associated with worse short-term and long-term survival in ST-elevation myocardial infarction.Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis.Effects of tight computerized glucose control on neurological outcome in severely brain injured patients: a multicenter sub-group analysis of the randomized-controlled open-label CGAO-REA studyObese reproductive-age women exhibit a proatherogenic inflammatory response during hyperglycemia.Blood glucose management in the patient undergoing cardiac surgery: A review.Insulin suppresses the expression of amyloid precursor protein, presenilins, and glycogen synthase kinase-3beta in peripheral blood mononuclear cells.Cytokine-mediated inflammation is independently associated with insulin sensitivity measured by the euglycemic insulin clamp in a community-based cohort of elderly menMeal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes.Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress.High plasma 5-hydroxyindole-3-acetic acid concentrations in subjects with metabolic syndrome.C-Reactive protein reactions to glucose-insulin-potassium infusion and relations to infarct size in patients with acute coronary syndromes.Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized PatientsAdmission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics.Adiponectin: a key fat-derived molecule regulating inflammation.Effect of local insulin injection on wound vascularization in patients with diabetic foot ulcer.Glucose-insulin-potassium techniques in cardiac surgery: historical overview and future perspectives.Insulin infusion therapy for myocardial infarction.Acute modulation of toll-like receptors by insulinTCF7L2 polymorphism is associated with low nitric oxide release, endothelial dysfunction and enhanced inflammatory response after myocardial infarction.Interrelationships between inflammation, C-reactive protein, and insulin resistance.Blood glucose control in critical care patients - a review of the literature.Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patientsEffect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE).Vascular effects of rapid-acting insulin analogs in the diabetic patient: a reviewBlood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction.Hibernating myocardium: pathophysiology, diagnosis, and treatment.An overview of glycemic control in the coronary care unit with recommendations for clinical management.Insulin says NO to cardiovascular disease.Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?Glycemic management in the inpatient setting.Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease.Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications.A challenge to the metabolic approach to myocardial ischaemia.Comparative effects of acute hypoglycemia and hyperglycemia on pro-atherothrombotic biomarkers and endothelial function in non-diabetic humans.Evaluation of buspirone on streptozotocin induced type 1 diabetes and its associated complications.Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
P2860
Q24813295-8133D442-931B-46B7-AA97-495BDCBC26E4Q26822374-48F60CF8-5B56-46B5-9547-8ACAB1749200Q33203601-7EBCD45B-F377-4041-A021-AB3380F64020Q33412579-851627A6-855F-40D4-BED4-43ED024FF73BQ33622028-B82374DB-577C-46E8-AEB7-4F2C490FF86BQ34002421-19FE6E20-DB67-4CC2-AB8C-1063DB8EF1E5Q34241723-8A37BEA7-1C57-4897-968D-311D2F50CA3EQ34398799-7C46E8CB-A917-4334-8189-9169042DE536Q34574042-5D0722B8-739C-4044-9308-27DA0F4F12B7Q35001864-A04705EE-1F5A-49B8-BCC6-4701D88E9DAEQ35040719-3B3DD574-9E42-44C5-9896-97CC5AFB672AQ35228483-F36CAF19-0CB0-4131-A015-5CE89244C6EBQ35565342-6AC5A721-CE07-4E63-9E75-D0F9D1C6C3C0Q35620210-E28A835D-065F-41D8-AB2B-12B585135C03Q35859423-9E37778B-D619-44D0-88EF-5DFE8CCA90BAQ35912987-1AFAE866-3361-4B5D-9956-0B3D68A90561Q36102103-ECD08A27-6606-49FC-9786-4CA95DAA90EBQ36150821-9D94119E-33D2-4FDF-AB09-685BC493A3AEQ36524599-CBD6E6A4-FB8E-4412-B7E4-6115A15F2CD9Q36588704-DBD322AD-5718-4539-A0E8-0F29420FBE40Q36675392-1CEA2AF4-01CD-4369-9240-5D3EAFB46794Q36842069-908BF74B-2D26-4968-9D1F-3B7650794966Q36897309-CF125743-76D2-41D3-8488-4DA99C9F4219Q36902768-2316C75E-2B8F-450F-97B2-7F4100261B45Q36947210-79737705-0159-45BA-BFB1-85C74E38753FQ37106033-F0C50166-CAEC-4B36-AB38-A8B540A3F476Q37106424-9EBD1B2B-8388-4ACC-B61A-157AE72C4D54Q37167474-C7735435-CCCF-4E9D-84E3-6434C8828826Q37311107-61B942CF-C6A5-418B-AC0A-17944DACB6FAQ37445512-117F6642-B99A-40CB-B48A-B2715CFCC196Q37453099-15D37C17-D8C6-4718-A58B-23C47057CF66Q37807194-05B6053B-F6FF-429D-8509-1FA1CBBBA273Q37898749-03AD04C0-48FF-49CC-A1C5-F9B9E97B1FA7Q38012072-F7AF06E4-F771-40A7-BF0C-529309A95DD8Q38027785-02897226-3A9C-4282-9132-EF458D6C008BQ38551004-D5CBD879-9286-418C-8A19-4E01840DCB0EQ40434641-CB14A0FD-1642-4C07-8791-D1E18B73E48BQ41739316-8CD8F171-A911-491C-B6B0-26ABF18963F8Q41921965-8FFD6467-8A3C-4B99-9AA7-EB35D19272A0Q42021514-63A1FD9E-BB08-45BF-8A85-0C1224C03445
P2860
Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Anti-inflammatory and profibri ...... evation myocardial infarction.
@en
Anti-inflammatory and profibri ...... evation myocardial infarction.
@nl
type
label
Anti-inflammatory and profibri ...... evation myocardial infarction.
@en
Anti-inflammatory and profibri ...... evation myocardial infarction.
@nl
prefLabel
Anti-inflammatory and profibri ...... evation myocardial infarction.
@en
Anti-inflammatory and profibri ...... evation myocardial infarction.
@nl
P2093
P1433
P1476
Anti-inflammatory and profibri ...... evation myocardial infarction.
@en
P2093
Ahmad Aljada
Ajay Chaudhuri
Arindam Bandyopadhyay
David Janicke
Debbie Hoffmeyer
Devjit Tripathy
Husam Ghanim
Janeen Calieri
Michael F Wilson
Paresh Dandona
P304
P356
10.1161/01.CIR.0000116762.77804.FC
P407
P577
2004-02-02T00:00:00Z